Federated Hermes’s Ambrx Biopharma Inc AMAM Stock Holding History

Federated Hermes’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-330,949	Closed	-$4.71M	–	2177
2023 Q4	$4.71M	Sell	330,949 -2,064,918	-86%	-$23.5M	0.01%	742
2023 Q3	$27.6M	Buy	+2,395,867	New	+$32.6M	0.07%	296

Federated Hermes's AMAM Position: Q1 2024 in Review

Federated Hermes sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 330,949 shares — an estimated $4.71M sold.

Federated Hermes first reported a position in AMAM in Q3 2023 and held it in 2 quarters. The position peaked at $27.6M in Q3 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Federated Hermes reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Federated Hermes sold 330,949 Ambrx Biopharma Inc shares in Q1 2024, an estimated $4.71M.
Federated Hermes first reported a position in Ambrx Biopharma Inc in Q3 2023 and held it in 2 quarters.
Federated Hermes's Ambrx Biopharma Inc position peaked at $27.6M in Q3 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.